Yichang Hec Changjiang Pharmaceutical Co. Ltd. announced internal dealings under Rule 22 of the Hong Kong Code on Takeovers and Mergers on June 11, 2025. CICC Financial Trading Limited, an exempt principal trader connected with the Offeror, disclosed the closing and unwinding of proprietary positions involving 400,000 shares on June 10, 2025. These dealings were executed for CICC's own account, involving both purchase and sale transactions.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.